Expression of insulinoma-associated protein 1 in non–small cell lung cancers: a diagnostic pitfall for neuroendocrine tumors

INSM1 Is a Highly Specific Marker of Neuroendocrine Differentiation in Primary Neoplasms of the Gastrointestinal Tract, Appendix, and Pancreas

(2020) Kelsey E McHugh et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Diagnostic Value of Insulinoma-Associated Protein 1 (INSM1) and Comparison With Established Neuroendocrine Markers in Pulmonary Cancers: A Comprehensive Study and Review of the Literature

(2020) Johan Staaf et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Expression of novel neuroendocrine marker insulinoma-associated protein 1 (INSM1) in genitourinary high-grade neuroendocrine carcinomas: An immunohistochemical study with specificity analysis and comparison to chromogranin, synaptophysin, and CD56

(2020) Jie-Fu Chen et al.   PATHOLOGY RESEARCH AND PRACTICE

INSM 1 Expression in Primary and Metastatic Neuroendocrine Neoplasms of the Gastrointestinal and Pancreatobiliary Tracts

(2019) Iván González et al.   HISTOPATHOLOGY

INSM1 Expression in Peripheral Neuroblastic Tumors and Other Embryonal Neoplasms

(2019) Hannah Wang et al.   PEDIATRIC AND DEVELOPMENTAL PATHOLOGY

Insulinoma-Associated Protein 1 Immunostain: A Diagnostic Tool for Pulmonary Small Cell Carcinoma in Cytology

(2018) Erika F. Rodriguez et al.   ACTA CYTOLOGICA

INSM1 is a Sensitive and Specific Marker of Neuroendocrine Differentiation in Head and Neck Tumors

(2018) Lisa M. Rooper et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens

(2018) Erika E. Doxtader et al.   CANCER CYTOPATHOLOGY

Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate

(2018) Wei Xue et al.   HUMAN PATHOLOGY

INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma

(2018) Akihiko Yoshida et al.   MODERN PATHOLOGY

Update on Immunohistochemistry for the Diagnosis of Lung Cancer

(2018) Kentaro Inamura   Cancers

INSM1 is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma

(2018) Mohammed T. Lilo et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections

(2018) Sanjay Mukhopadhyay et al.   MODERN PATHOLOGY

Tripple marker composed of p16, CD56 and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens

(2018) Marián Švajdler et al.   HUMAN PATHOLOGY

A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases

(2017) Shiho Kuji et al.   GYNECOLOGIC ONCOLOGY

Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)

(2017) Patrick S. Rush et al.   JOURNAL OF CUTANEOUS PATHOLOGY

Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor

(2017) Masahiko Tanigawa et al.   Medical Molecular Morphology

INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms

(2015) Jason N. Rosenbaum et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer

(2015) Kosuke Fujino et al.   AMERICAN JOURNAL OF PATHOLOGY

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology